|
Headquartered in Brussels, ProSeed Capital Holdings CVA is a dynamic holding company active primarily in Europe, the U.S. and Israel with offices in Brussels, Boston, and Tel-Aviv. Through its independent business units, ProSeed's main activities consist of seed investments, advisory and consulting services and corporate development services for biomedical companies.
ProSeed Capital
ProSeed Capital has a portfolio of early stage technology and life sciences investments in the US, Europe and Israel.
ProSeed Advisory Services
ProSeed is assisting and advising companies in the US, Europe, and Israel with their corporate development efforts, with special emphasis on identifying and approaching strategic partners and investors.
ProSeed Biotech Services
ProSeed Biotech Services, Inc. is a one stop shop providing due dilligence and business development services to its clients: pharmaceutical, biomedical and healthcare investors and companies in the US, Europe and Israel.
|
| Investor Extranet |
| Click here to access our investor extranet (password required) |
| News from Our Investments |
July 22nd, 2008
Amarin Proceeding to Phase 3 with AMR101 for Hypertriglyceridemia
more |
June 9th, 2008
Lifeline wins contracts to supply largest Canadian transplant programmes
more... |
April 2nd, 2008
Kamada Announces that it had Succesfully Met the Primary Endpoint in its US Phase III Clinical Trial with Intravenous AAT
more... |
March 10th, 2008
Lifeline division wins contracts to supply two leading transplant centres
more... |
January 10th, 2008
Amarin to Commence Phase II Trial with AMR101 in Age Associated Memory Impairment
more... |
January 8th, 2008
Lifeline Scientific announces successful completion of IPO
more... |
December 5th, 2007
Amarin acquires Ester Neurosciences
more... |
October 2nd, 2007
Lifeline Scientific's LifePort Kidney Transporter demonstrates clear advantages over traditional ice box storage
more... |
March 1st, 2007
Kamada begins phase III clinical trial in the U.S
more... |
| Archived news releases |
|
